<DOC>
	<DOCNO>NCT01349894</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Spiracur SNaP® Wound Care System treatment skin cancer excision sit split thickness skin graft ( STSG ) . The secondary purpose compare prospective patient retrospectively treated skin cancer excision sit STSGs evaluate efficacy safety .</brief_summary>
	<brief_title>SNaP Wound Care System Over Skin Cancer Excision Sites Split Thickness Skin Grafts ( STSGs )</brief_title>
	<detailed_description />
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>Skin cancer excision site and/or STSG source wind part body include head neck , torso , extremity . Any type skin graft also eligible inclusion study . Wound &lt; 16 cm great diameter Subject ≥ 18 year age Female subject childbearing potential must willing take urine pregnancy test prior start study Subject willing able sign inform consent Woundrelated cellulitis Wound locate area amenable forming airtight seal Subject untreated osteomyelitis Subject allergic wound care product Wound expose blood vessel suitable negative pressure therapy Subject actively participate clinical trial conflict current study Subject fistula Subject pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>